PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
Jianwei Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yupei Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 52
Related Papers
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|141
SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway
|Cell Death and Disease|2023|82
High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis
|Journal of Hematology & Oncology|2021|68
CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
|Journal of Cancer|2020|56
Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59
|Cell Death and Disease|2019|49